past
decad
wit
enorm
technolog
improv
toward
develop
simpl
costeffect
accur
rapid
diagnost
test
detect
identif
infecti
pathogen
among
dengu
viru
etiolog
agent
mosquitoborn
dengu
diseas
one
import
emerg
infecti
patholog
nowaday
dengu
fever
may
caus
potenti
deadli
hemorrhag
symptom
endem
tropic
subtrop
world
also
seriou
threat
temper
countri
develop
world
effect
diagnost
dengu
abl
discrimin
among
four
antigen
relat
dengu
serotyp
fulfil
requir
success
decentr
pointofcar
test
harsh
environment
condit
found
tropic
region
accur
identif
circul
serotyp
crucial
success
implement
vector
control
program
base
reliabl
epidemiolog
predict
paper
briefli
summar
limit
main
convent
techniqu
biomolecular
diagnosi
dengu
diseas
critic
review
relev
biosensor
rapid
diagnost
test
develop
implement
report
far
pointofcar
test
dengu
infect
invalu
contribut
microfluid
nanotechnolog
encompass
whole
paper
evalu
concern
rapid
diagnost
test
foreseen
technolog
improv
field
also
overview
diagnosi
dengu
infecti
tropic
diseas
well
dengu
diseas
caus
femal
aed
spp
mosquito
infect
rnacontain
dengu
viru
classifi
categori
agent
center
diseas
control
prevent
cdc
usa
import
arthropodborn
diseas
present
affect
countri
worldwid
threaten
around
half
world
popul
mainli
urban
popul
tropic
world
seriou
threat
temper
countri
deforest
process
human
popul
burst
collaps
vector
control
program
tropic
develop
countri
well
enorm
worldwid
expans
air
travel
larg
contribut
symptom
highli
nonspecif
usual
aris
incub
period
two
week
coincid
sudden
viral
particl
blood
potenti
caus
fatal
hemorrhag
fever
dengu
diseas
may
occur
form
four
antigen
relat
viral
serotyp
dengu
virus
capsid
three
structur
protein
includ
glycoprotein
respons
attach
host
cell
reconnaiss
specif
antibodi
also
possess
singlestrand
rna
ssrna
genom
kbp
kda
singl
openread
frame
orf
flank
two
nontransl
region
end
plu
seven
sequenc
codifi
nonstructur
protein
wellknown
nonstructur
protein
apart
common
less
danger
dengu
fever
dengu
hemorrhag
fever
dhf
even
dengu
shock
syndrom
dss
condit
requir
critic
healthcar
may
also
occur
infect
asymptomat
enorm
increas
dhf
dss
case
report
past
decad
america
report
world
health
organ
around
suspect
case
dengu
almost
confirm
dhf
fatal
case
brazilian
state
rio
de
janeiro
seriou
wide
report
outbreak
occur
period
account
case
dengu
fever
almost
total
number
case
brazil
around
case
dhf
despit
serotyp
caus
diseas
studi
southeast
asia
evidenc
higher
probabl
occurr
sever
symptom
secondari
infect
serotyp
probabl
reason
biosensor
describ
ahead
nucleicacid
immunolog
antibodi
antigen
biomark
predominantli
report
although
ident
seropreval
rate
regist
asian
caribbean
new
mother
neonat
much
higher
incid
dhf
dss
occur
southeast
asia
caribbean
probabl
result
differ
circul
dengu
genotyp
genet
resist
human
popul
differ
vector
control
detail
explan
fact
may
crucial
avoid
america
alarm
scenario
southeast
asia
africa
notif
dengu
arbovir
infect
probabl
highli
underestim
absenc
approv
vaccin
therapeut
effect
four
serotyp
accur
rapid
diagnos
urgent
need
deadli
form
diseas
longer
acut
febril
period
caus
dengu
infect
compar
caus
acut
fever
syndrom
report
howev
clinic
diagnosi
usual
insuffici
specif
identif
etiolog
agent
especi
diseas
surveil
purpos
henc
requir
definit
serolog
virolog
laboratori
confirm
highli
sensit
viru
isol
cultur
follow
immunofluoresc
microscopi
employ
denguespecif
antibodi
consid
goldstandard
convent
dengu
diagnosi
requir
highlevel
equip
manpow
due
low
replic
rate
dengu
viru
adequ
earli
diagnosi
apart
gener
drawback
serolog
test
name
hemagglutinationinhibit
hi
neutral
test
cumbersom
expens
significantli
nonspecif
monoclon
antibodi
captureenzym
link
immunosorb
assay
maceia
reversetranscript
polymeras
chainreact
rtpcr
mainli
use
routin
laboratori
diagnosi
dengu
infect
although
like
former
still
fail
accomplish
requir
success
decentr
diagnosi
tropic
develop
countri
simplic
economi
rapid
accuraci
featur
materi
togeth
emerg
paradigm
pointofcar
decentr
test
bioanalyt
clinic
correspond
nearpati
analysi
healthcar
unit
home
even
remot
region
nonskil
individu
includ
endus
reliabl
highthroughput
sampl
process
time
manner
ultim
envisag
pointofcar
test
tailor
test
mani
consist
wellknown
wide
avail
test
strip
format
also
call
immunochromatograph
lateralflow
test
may
thu
consid
valuabl
complement
convent
inthebench
analyt
techniqu
allow
remot
detect
also
rapid
inform
permit
improv
decis
make
process
eg
emerg
situat
well
reduc
amount
sampl
reach
laboratori
especi
undertak
simultan
determin
sever
analyt
multiplex
technolog
improv
bioelectron
driven
appear
mani
methodolog
analyt
devic
valuabl
altern
convent
laboratori
assay
rapid
accur
detect
infecti
pathogen
mani
commerci
immunoassay
kit
serolog
diagnosi
dengu
infect
base
maceia
alreadi
avail
usual
requir
long
assay
time
order
hour
timeconsum
sampl
process
includ
extens
wash
incub
step
difficult
consider
immunoassay
true
rapid
diagnost
test
articl
overview
publish
literatur
especi
date
last
decad
biosensor
rapid
diagnost
test
biomolecular
diagnosi
dengu
diseas
clinic
simpli
model
synthet
sampl
note
experiment
condit
biosensor
rapid
test
assay
synthet
target
biomark
may
differ
significantli
real
sampl
rtpcr
maceia
main
routin
laboratori
test
employ
worldwid
diagnosi
dengu
infect
describ
section
earli
diagnosi
import
hinder
develop
longterm
seriou
symptom
spread
dengu
diseas
pcr
pcrrelat
techniqu
employ
long
time
routin
diagnosi
viral
infect
includ
dengu
perform
pcr
amplif
predefin
dengu
genom
sequenc
greatli
depend
specif
predesign
primer
sequenc
order
conveni
target
desir
genom
region
one
biggest
challeng
molecular
diagnosi
dengu
virus
high
variabl
among
genom
sequenc
differ
serotyp
noncod
region
nr
dengu
viru
rna
near
bp
use
favor
target
purpos
nr
contain
conserv
sequenc
among
serotyp
well
serotypespecif
sequenc
thu
use
simultan
amplifi
rtpcr
dengu
serotyp
given
clinic
sampl
build
specif
primer
set
identifi
quantifi
one
serotyp
shown
studi
employ
highli
sensit
specif
fluorogen
detect
major
challeng
earli
dengu
diagnosi
rtpcr
small
one
week
period
avail
success
detect
viremia
infect
given
dengu
serotyp
usual
confer
lifelong
immun
serotyp
enhanc
suscept
remain
thu
accur
identif
preval
circul
serotyp
genotyp
may
crucial
predict
epidemiolog
implic
pattern
epidem
outbreak
rtpcr
even
abl
rapidli
detect
new
infect
serotyp
endem
area
therefor
context
epidemiolog
evolutionari
studi
pcrbase
techniqu
nest
pcr
singletub
multiplex
pcr
even
realtim
autom
pcr
find
extrem
use
serolog
fail
howev
pcrbase
method
need
stringent
qualiti
control
meticul
manipul
biolog
specimen
avoid
falseposit
result
due
easi
unwant
amplif
contamin
addit
serum
sampl
rtpcr
assay
must
store
extrem
low
temperatur
due
intrins
liabil
dengu
rna
genom
feasibl
mani
endem
area
measur
nonstructur
dengu
protein
mainli
specif
immunoglobulin
g
igg
igm
dengu
antibodi
frequent
chosen
prefer
serolog
test
typic
dengu
infect
elicit
stronger
specif
igm
igg
respons
primari
flavivir
infect
individu
never
immun
flavivir
vaccin
opposit
happen
secondari
infect
basi
eia
suitabl
distinguish
primari
secondari
dengu
infect
base
igmigg
ratio
hand
serum
suitabl
biolog
fluid
test
sinc
highli
stabl
tropic
temperatur
even
prolong
exposur
accordingli
colorimetr
igm
maceia
wide
use
techniqu
dengu
serolog
diagnosi
classic
maceia
assay
usual
cheaper
simpler
faster
inform
serolog
test
howev
maceia
test
alway
avail
resourcelimit
healthcar
set
moreov
cost
labbas
assay
gener
still
high
purchas
develop
countri
dengu
exist
especi
pointofcar
envisag
includ
endus
particular
igmbas
assay
wide
avail
util
dengueendem
countri
although
use
confirmatori
test
current
diseas
especi
first
day
ill
sinc
igm
antibodi
appear
blood
least
five
day
upon
infect
persist
thereaft
month
igm
biomark
acut
infect
igg
previou
primari
infect
concomit
detect
may
enhanc
diagnost
accuraci
conclus
classic
serolog
techniqu
dengu
diagnosi
gener
low
sensit
high
complex
long
assay
time
reduc
use
first
day
ill
mani
commerci
diagnost
kit
base
maceia
dengu
diagnosi
avail
predomin
type
immunossay
clinic
set
dengu
antigenbas
kit
particular
proven
highli
valuabl
rapid
onsit
screen
dengueinfect
travel
intern
airport
includ
countri
dengu
endem
utmost
import
quickli
forward
patient
medic
treatment
followup
healthcar
unit
possibl
drastic
diminish
burden
mosquito
control
measur
test
kit
limit
sensit
patient
acut
febril
ill
endem
area
relat
rapid
test
kit
claim
enhanc
rapid
sensit
specif
also
cite
elsewher
although
improv
detect
low
level
antigen
acutephas
serum
sampl
patient
secondari
infect
sever
strain
four
serotyp
circul
differ
geograph
region
still
requir
increas
reliabl
test
mani
kit
may
still
lack
valid
standard
multiinstitut
studi
may
necessari
interpret
serolog
result
frequent
conclus
misjudg
febril
ill
especi
flaviviros
eg
yellow
fever
viral
enceph
secondari
infect
due
crossreact
serotypespecif
dengu
antibodi
previou
infect
individu
previous
vaccin
yellow
fever
japanes
enceph
also
due
crossreact
serolog
analysi
may
use
diagnosi
dengu
infect
surveil
purpos
use
togeth
clinic
epidemiolog
data
confirmatori
although
low
util
earli
diagnosi
serolog
test
usual
requir
test
pair
serum
sampl
collect
acut
convalesc
phase
tediou
timeconsum
gener
maceia
rtpcr
assay
requir
rang
laboratori
facil
skill
manpow
prohibit
pointofcar
test
resourcelimit
set
fundament
scientist
engin
involv
research
develop
biodiagnost
devic
techniqu
usual
employ
term
biosensor
describ
medic
commun
peopl
gener
know
preferenti
rapid
diagnost
test
rapid
test
usual
seen
simpl
inexpens
devic
qualit
even
quantit
biodetect
abl
use
nonspecif
skill
healthcar
profession
within
clinic
set
also
endus
patient
domest
inthefield
context
term
biosensor
usual
appli
prototyp
new
bioanalyt
devic
frequent
inthebench
develop
stage
proofofconcept
demonstr
concept
also
use
describ
new
biosens
techniqu
methodolog
even
though
commit
exist
toward
develop
fulli
autom
desir
portabl
diagnost
devic
bulki
analyt
techniqu
laboratori
analysi
biosensor
commonli
tailor
highli
sensit
specif
fast
responseproport
last
requir
howev
lose
import
ongo
advanc
signal
process
technolog
proceed
although
common
literatur
specif
character
biosensor
base
high
sensit
select
question
issu
sinc
gener
analyt
techniqu
devic
ultim
envisag
goal
biosensor
scheme
research
level
proceed
toward
prototyp
devic
product
develop
level
surprisingli
concept
biosensor
restrict
mainli
laboratori
henc
belong
scientif
limit
domain
mani
obstacl
aris
attempt
go
ie
massproduct
commerci
fact
still
limit
avail
commerci
biosensor
may
due
mainli
lack
appropri
technolog
costeffect
manufactur
lack
fundament
scientif
knowledg
moreov
real
world
biosensor
market
fort
health
especi
inthefield
diagnosi
develop
countri
pose
hard
challeng
especi
demand
highthroughput
test
relat
massproduct
thu
common
highperform
standard
paradigm
convent
laboratorybas
analyt
devic
usual
reli
high
sensit
select
reproduc
tend
shift
pointofcar
toward
pursuit
simpler
cheaper
faster
diagnost
test
favor
desir
characterist
rapid
diagnost
test
field
applic
frequent
achiev
expens
decreas
analyt
accuraci
although
maintain
reliabl
least
certain
level
ideal
test
must
produc
form
portabl
miniatur
autom
selfpow
readout
devic
coupl
dispos
peripher
eg
test
strip
biorecognit
event
occur
dispos
necessari
avoid
contamin
deal
infecti
agent
guarante
commerci
viabil
cheap
microfabr
devic
clinic
diagnosi
howev
import
prior
purif
chemic
modif
step
rel
underestim
develop
simpl
inexpens
test
especi
relev
case
complex
biolog
sampl
case
dna
detect
clinic
sampl
still
problem
usual
low
level
dna
human
genom
dna
level
blood
instanc
may
fold
pathogen
dna
typic
blood
infect
may
significantli
hamper
achiev
good
select
level
suitabl
inclus
sampl
prepar
step
thu
undertaken
dispos
chipbas
microfluid
labonachip
devic
format
see
follow
section
detail
obvious
devic
entir
compli
exquisit
requir
ideal
rapid
diagnost
test
constitut
rather
somewhat
midterm
heavi
laboratori
analyt
devic
expect
howev
simultan
complianc
pointofcar
requir
analyt
reliabl
may
defin
desir
balanc
toward
product
improv
devic
success
inthefield
applic
short
distinct
biosensor
rapid
diagnost
test
alway
straightforward
paper
care
taken
assign
concept
biosensor
rapid
test
respect
inthebench
fulli
develop
analyt
devic
howev
usual
easi
assess
exact
development
stage
devic
reason
establish
distinct
major
concern
ahead
past
decad
advanc
microand
nanofabr
techniqu
base
planar
silicon
industri
integr
circuit
leverag
develop
dispos
singleus
chiplik
biosensor
improv
perform
name
term
sensit
select
amen
pointofcar
test
way
overcom
usual
problem
low
stabil
normal
room
temperatur
usual
limit
biosensor
shelflif
month
difficult
steril
due
labil
element
modest
select
due
interf
substanc
present
complex
biolog
sampl
current
biosensor
mani
test
produc
form
simpl
immunochromatograph
strip
inexpens
easi
visual
colorimetr
detect
usual
requir
driedstor
reagent
addit
instrument
miniatur
trend
greatli
obviat
usual
limit
labbas
techniqu
provid
lower
consumpt
power
sampl
volum
costli
hazard
reagent
shorter
assay
time
lower
oper
cost
improv
portabl
compar
bulki
laboratori
method
especi
import
pointofcar
diagnosi
tropic
develop
countri
dengu
endem
highthroughput
microarray
technolog
particular
proven
use
simultan
test
dengu
viru
arbovirus
circul
given
region
well
screen
pathogen
respons
occurr
denguelik
symptom
nevertheless
standard
technolog
still
expens
complex
biolog
analysi
pointofcar
usag
even
routin
laboratori
test
limit
current
microarray
includ
strong
sampl
concentr
depend
limit
resolut
high
biomolecul
densiti
difficult
array
scalingdown
recent
labonachip
devic
emerg
secondgener
chip
suitabl
integr
modul
sampl
process
analysi
singl
devic
labonachip
scheme
offer
enhanc
flexibl
discriminatori
abil
convent
biosensor
chip
although
minim
sampl
prepar
procedur
ultim
goal
toward
devic
simplif
easinesstous
often
labonachip
devic
also
includ
prior
calibr
step
measur
dna
analysi
particular
usual
requir
extens
sampl
process
take
consider
dna
easili
amplifi
biomolecul
modul
dna
amplif
pcrbase
techniqu
usual
requir
microfluid
devic
owe
extrem
small
concentr
dna
biolog
fluid
use
probe
dna
biosensor
short
oligonucleotid
yield
rel
exact
sequenc
identif
longer
dna
fragment
provid
higher
toler
sequenc
mismatch
henc
improv
abil
detect
diverg
strain
pcrfree
ie
unamplifi
dna
detect
pursu
along
dna
chip
develop
moder
success
progress
area
may
extrem
use
accur
biomolecular
detect
dengu
infect
unambigu
serotyp
identif
well
howev
current
labonachip
devic
despit
simpler
convent
laboratori
analyt
apparatu
still
requir
complex
somewhat
expens
fabric
procedur
onto
plastic
glass
substrat
thu
sever
limit
afford
avail
poor
countri
futur
develop
new
biosensor
platform
may
eventu
benefit
materi
improv
analyt
perform
eg
paperbas
materi
especi
term
enhanc
sensit
well
simplic
costeffect
allow
wide
util
develop
countri
affect
dengu
diseas
subsect
ahead
refer
overview
avail
literatur
report
methodolog
devic
detect
identif
specif
biomolecul
clinic
synthet
origin
relat
dengu
viru
three
first
subsect
concern
three
main
type
physic
transduct
mechan
electrochem
optic
piezoelectr
fourth
compil
inform
concern
perform
paramet
biosensor
among
report
dengu
biosensor
literatur
immunochip
employ
two
specif
monoclon
antibodi
immobil
piezoelectr
transduc
detect
glycoprotein
protein
multiantibodi
coat
allow
captur
sever
differ
antigen
increas
overal
mass
thu
detect
signal
layout
exhibit
higher
sensit
convent
eia
short
respons
time
min
anoth
work
instead
convent
antibodi
immobil
onto
quartz
crystal
microbal
qcm
surfac
piezoelectr
detect
antigen
thin
film
molecularli
imprint
polym
mip
specif
dengu
viral
protein
form
polymer
monom
onto
qcm
chip
surfac
work
claim
first
applic
mip
clinic
earli
diagnosi
dengueinfect
biolog
sampl
polymer
process
lead
format
aminoacidlik
caviti
select
recogn
epitop
site
dengu
protein
fig
artifici
receptor
apart
avoid
need
synthes
monoclon
antibodi
provid
improv
assay
specif
avoid
contamin
anchor
nonspecif
bind
protein
molecul
imprint
analytespecif
polym
caviti
addit
clinic
sampl
often
requir
dilut
pretreat
effect
analysi
antigen
four
serotyp
confirm
pcr
andor
viru
isol
success
detect
mipqcm
chip
whose
result
agre
convent
eia
abl
diagnos
dengu
infect
less
h
exhibit
good
sensit
specif
compar
report
monoclon
antibodybas
chip
futur
use
subgroupspecif
glycoprotein
crossreact
epitop
templat
may
use
distinguish
dengu
serotyp
recent
piezoelectr
genosensor
detect
oligonucleotid
sequenc
obtain
rtpcr
develop
specif
hybrid
complementari
oligucleotid
immobil
onto
qcm
surfac
amplif
detect
signal
achiev
interconnect
oligonucleotideattach
gold
nanoparticl
gnp
hybrid
stepwis
layerbylay
process
gold
surfacegraft
oligonucleotid
duplex
sinc
primari
bind
event
amplifi
success
hybrid
event
complementari
oligonucleotid
probe
target
also
detect
sensit
also
specif
dna
hybrid
greatli
increas
probe
test
four
serotyp
respond
posit
homolog
genom
region
qcm
method
abl
detect
rna
plaqu
titer
low
pfu
ml
exhibit
linear
concentr
rang
pfu
ml
moreov
sensit
specif
compar
realtim
pcr
method
claim
addit
method
labelfre
thu
avoid
usual
drawback
signal
lost
gradual
leakag
label
requir
expens
equip
certainli
valuabl
featur
inthefield
applic
spite
method
piezoelectr
biosens
liquid
phase
prone
complex
interact
interfaci
paramet
innumer
environment
interfer
detect
signal
includ
small
air
fluctuat
reason
hardli
applic
outsid
laboratori
facil
highli
uncontrol
condit
recent
selfassembl
monolay
sam
base
coval
immobil
biorreceptor
conjug
dengu
antigen
bovin
serum
albumin
bsa
perform
onto
gold
chip
surfac
immunoassay
detect
specif
igm
dengu
antibodi
serum
indirect
competit
inhibit
bsa
typic
applic
employ
block
reagent
minim
nonspecif
bind
interfer
typic
exist
clinic
sampl
thu
improv
detect
select
work
also
employ
surfac
plasmon
reson
spr
measur
increas
reson
angl
surfacedeposit
sampl
presenc
dengu
viru
spr
techniqu
use
way
circumv
typic
signal
resolut
optic
fiber
photon
devic
unlik
tradit
immunoassay
format
spr
allow
realtim
labelfre
analysi
nevertheless
miniatur
optic
electron
compon
sprbase
devic
still
difficult
issu
aim
pointofcar
applic
instead
common
method
use
oligonucleotid
probe
coval
link
label
eg
fluorophor
cheap
sampl
irradi
excit
wavelength
dye
differ
laser
sourc
emiss
light
beam
split
two
photodetector
tune
emiss
wavelength
one
dye
monitor
sampl
simultan
photodetector
detect
correspond
particlelabel
dye
interact
measur
fluoresc
fluctuat
time
c
crosscorrel
analysi
two
fluoresc
spectra
reveal
sole
virusantibodi
interact
crosscorrel
analysi
allow
determin
amount
kinet
paramet
interact
speci
simpl
dengu
biosensor
employ
liposomelabel
univers
reporterprob
bind
dengu
serotyperel
target
four
sequencespecif
probe
one
serotyp
report
liposom
allow
signal
amplif
rapid
electrochemiluminesc
detect
within
min
serotypediscrimin
dengu
genom
amplif
obtain
nucleicacid
sequencebas
amplif
nasba
pcrbase
techniqu
thermalcycl
amplif
rna
signific
advantag
electrochemiluminesc
fluoresc
affect
background
optic
signal
come
biolog
sampl
make
techniqu
use
detect
low
level
biomolecul
sandwich
techniqu
integr
liposomecoupl
reporterprob
membraneimmobil
biotinyl
captureprob
amount
tag
liposom
proport
sampl
rna
unlik
fluoresc
chemiluminesc
requir
excit
optic
sourc
subject
quench
phenomena
moreov
also
highli
sensit
rel
low
costli
parallel
liposomebas
signal
amplif
provid
excel
signaltonois
sn
ratio
sinc
liposom
carri
mani
fluorophor
molecul
unfortun
nasba
requir
care
handl
store
molecular
target
sinc
rna
inher
much
liabl
dna
although
result
decreas
risk
contamin
also
limit
use
rna
amplificationbas
techniqu
inthefield
applic
includ
epidemiolog
studi
studi
cold
probe
unlabel
oligonucleotid
probe
use
serotyp
prevent
falseposit
signal
due
crossreact
serotyp
given
fact
correctli
identifi
wherea
exhibit
signific
crossreact
serotyp
design
cold
probe
would
valuabl
contribut
accur
identif
perform
three
avail
maceia
scheme
chemiluminesc
colorimetr
commerci
panbio
compar
pioneer
chemiluminesc
optic
fiber
immunosensor
detect
igm
antibodi
serum
sampl
immunosensor
exhibit
good
specif
excel
sensit
lower
detect
limit
three
maceia
format
sensit
least
higher
respect
colorimetr
test
particular
interest
diagnosi
asymptomat
dengu
diseas
rapid
also
higher
chemiluminesc
immunosensor
chemiluminesc
maceia
howev
difficulti
surfac
bind
might
explain
poorer
reproduc
optic
fiber
sensor
compar
maceia
microspherebas
immunoassay
coval
bind
antigen
antibodi
microspher
microbead
consid
promis
altern
enzymat
label
maceia
owe
rapid
abil
multiplex
serolog
analysi
well
possibl
test
optic
opaqu
sampl
magnet
particl
allow
improv
detect
specif
magnet
control
remov
nonspecif
bound
magnet
bead
magnet
wash
thu
avoid
elimin
timeconsum
wash
step
unspecif
bound
molecul
biosensor
fabric
standard
complementari
metal
oxid
semiconductor
cmo
manufactur
develop
format
analog
eia
detect
dengu
igg
clinic
serum
sampl
via
magnet
label
sensit
dispos
prototyp
form
array
sensor
chip
similar
eia
platform
built
inexpens
straightforward
mass
product
technolog
claim
easili
appli
exist
eia
protocol
reagent
unfortun
magnet
wash
intrins
variabl
commerci
magnet
bead
may
decreas
sensit
detect
innov
microfluid
immunoassay
system
simultan
detect
dengu
igm
igg
oper
flowinject
analysi
fia
mode
contain
sampl
pretreat
modul
enhanc
sensit
system
use
magnet
bead
attach
captur
antibodydengu
viru
complex
specif
recogn
serum
igg
igm
onchip
magnet
isol
sandwichbas
bead
complex
specif
fluorescentlabel
secondari
igg
igm
dengu
antibodi
bound
whole
complex
transport
detect
modul
purif
complex
serum
sampl
respons
improv
detect
limit
pg
assay
time
within
min
slight
variat
liposomebas
electrochemiluminesc
setup
describ
report
refer
immobil
magnet
spherecaptur
probe
complex
onto
perman
magnet
detect
region
built
microfluid
format
liposom
fill
dye
molecul
detect
synthet
rna
sequenc
fluoresc
microscopi
inher
signal
amplif
henc
increas
sensit
base
upon
two
layout
optic
biosensor
polyethersulfon
membraneimmobil
univers
reporterprob
dyefil
liposom
develop
dengu
genom
detect
scheme
appli
specif
identif
four
dengu
viru
serotyp
singl
multianalyt
assay
instead
four
independ
assay
design
multianalyt
sensor
base
prior
investig
crossreact
four
serotyp
undertaken
four
independ
serotypespecif
singleanalyt
biosensor
ie
singl
captur
zone
among
biosensor
serotyp
highli
specif
wherea
serotyp
show
crossreact
studi
final
multianalyt
biosensor
amplifi
dengu
viru
rna
sequenc
serotyp
reliabl
correct
serotyp
identif
obtain
biosensor
also
success
detect
concurr
infect
serotyp
mix
clinic
sampl
take
advantag
previous
known
technolog
immunochromatograph
rna
detect
sandwich
scheme
employ
labonachip
format
compris
sampl
prepar
detect
separ
modul
cell
lysi
rna
purif
nasba
detect
system
show
feasibl
detect
messeng
ribosom
genom
rna
way
liposom
report
probe
bead
incub
amplifi
target
prior
introduct
mixtur
microchannel
sandwich
complex
magnet
captur
detect
fluoresc
microscopi
unlik
previous
describ
biosensor
nonion
surfact
use
easili
disrupt
liposom
way
rapid
releas
dozen
thousand
fluorophor
molecul
occur
bulk
solut
thu
result
remark
increas
fluoresc
signal
owe
elimin
fluorophor
selfquench
larg
signal
amplif
bind
event
provid
sensit
quantit
fast
detect
biolog
target
anoth
work
setup
success
appli
accur
rna
identif
amplif
four
dengu
viru
serotyp
within
min
identif
serotyp
unambigu
crossreact
significantli
assay
previous
optim
synthet
rna
fragment
achiev
similar
sensit
standard
electrochemiluminesc
detect
addit
lyse
liposom
approach
compar
intact
liposom
one
first
achiev
slightli
better
perform
howev
lyse
liposom
strategi
intrins
complex
design
intact
liposom
sinc
second
channel
sampl
flow
switch
need
solv
problem
may
implic
turn
back
intact
liposom
layout
although
decreas
fluorophor
concentr
order
lower
selfquench
enhanc
signal
intact
liposom
unfortun
fluoresc
optic
transduc
usual
requir
expens
complex
microscop
electron
peripher
hinder
costeffect
miniatur
devic
toward
truli
pointofcar
diagnost
often
ultim
limit
singl
molecul
detect
submillilit
level
dramat
increas
probabl
occurr
falseposit
falseneg
result
therefor
techniqu
abl
directli
detect
unamplifi
intrins
analyt
signal
clinic
sampl
still
envisag
singlemolecul
detect
still
lack
aim
singl
dengu
viral
particl
detect
serum
sampl
bind
denguespecif
antibodi
microfluid
array
coupl
detect
fluoresc
crosscorrel
spectroscopi
fcc
microfluid
array
confin
dengu
bulk
solut
femtolit
volum
wherea
recent
develop
fcc
techniqu
abl
detect
singl
bind
event
dengu
viru
particl
specif
dengu
antibodi
method
base
crosscorrel
fluoresc
spectra
fluctuat
viru
target
label
fluorophor
exhibit
differ
color
upon
excit
perfect
crosscorrel
occur
two
differ
color
reactant
bind
fig
fcc
deriv
fluoresc
correl
spectroscopi
fc
techniqu
singl
molecul
detect
simultan
character
molecular
interact
homogen
solut
use
fcc
permit
surpass
two
main
limit
autocorrel
analysi
provid
fc
includ
limit
sensit
low
concentr
speci
sinc
diffus
time
virustarget
complex
larger
free
target
henc
autocorrel
profil
mixtur
almost
exclus
deriv
unbound
target
depend
geometr
size
reactant
caus
undistinguish
format
virustarget
complex
true
event
target
selfaggreg
fals
posit
conclus
given
reliabl
crosscorrel
biosens
probetarget
complex
format
mention
studi
fcc
integr
highthroughput
microfluid
devic
prove
use
method
ultralow
detect
singl
viru
particl
without
amplif
procedur
howev
clinic
use
strategi
implic
extens
singl
viral
particl
detect
femtolit
sampl
volum
microlitersubmillilit
domain
typic
clinic
sampl
order
reach
improv
sensit
rang
furthermor
techniqu
suffer
basic
constraint
optic
detect
particularli
expens
high
complex
analyt
apparatu
complex
data
process
among
report
electrochem
biosensor
suitabl
combin
potenti
dispos
microfluid
cartridg
interdigit
ultramicroelectrod
array
minipotentiostat
amperometr
detect
nasbaamplif
rna
sandwich
hybrid
assay
report
probe
molecul
coupl
redox
labelentrap
liposom
signal
amplif
captur
probe
coupl
superparamagnet
microbead
magnet
isol
magnet
detect
region
upon
captur
lyposom
lyse
releas
redox
marker
compar
standard
labbench
potentiostat
integr
minipotentiostat
reach
detect
limit
time
lower
small
portabl
inexpens
devic
therefor
viabl
altern
similar
scheme
fluoresc
detect
anoth
work
report
genosensor
employ
ferrocen
electroact
hybrid
indic
preferenti
attach
singlechain
dna
result
unequ
ferrocen
concentr
near
electrod
surfac
therefor
distinct
electrochem
respons
use
simpl
electrochem
detect
cyclic
voltammetri
denguerel
oligonucleotid
synthet
sequenc
chitosanco
glassi
carbon
electrod
recent
electrochem
biosensor
employ
concanavalina
immobil
onto
gold
electrod
gnp
polyvinyl
butyr
electrochem
imped
spectroscopi
ei
sensit
effect
techniqu
probe
interfaci
properti
modifi
electrod
use
work
compar
confirm
dengu
fever
dhf
noninfect
sera
sampl
distinct
pattern
impedimetr
respons
observ
ascrib
differ
glycoprotein
pattern
differ
sera
lectin
specif
concanavalina
glycoprotein
carbohydr
moieti
use
develop
specif
biosensor
sugar
therefor
biosensor
potenti
applic
recognit
differ
serum
glycoprotein
pattern
convent
ei
toxic
redoxcoupl
fe
cn
usual
ad
electrolyt
solut
measur
farada
process
although
longterm
presenc
may
reduc
bioactiv
protein
layer
immobil
onto
electrod
surfac
certainli
favor
point
util
nonfarada
immunosensor
without
ad
reagent
pointofcar
applic
accordingli
recent
work
describ
develop
nonfarada
labelfre
ei
biosensor
thermal
inactiv
dengu
viru
serotyp
immobil
onto
solgel
deriv
barium
strontium
titan
bst
thin
film
precoat
interdigit
electrod
modifi
organ
sam
coplanar
symmetr
structur
fingerlik
electrod
oper
singl
work
electrod
bst
thin
film
act
middl
dielectr
layer
sandwich
capacitor
ie
effect
sens
medium
manner
bst
film
provid
better
coupl
electr
field
sens
surfac
rather
penetr
deep
insid
electrolyt
biosensor
render
signal
output
directli
correl
serum
concentr
dengu
antibodi
signal
chang
upon
captur
antibodi
attribut
surfac
conduct
chang
fact
increas
interfaci
capacit
observ
biomolecul
immobil
electrod
surfac
unlik
convent
electrochem
immunosensor
sensor
use
deioniz
water
electrolyt
suitabl
integr
extern
electr
measur
circuit
microfluid
channel
similar
detect
scheme
fieldeffect
transistor
fet
biosensor
rtpcr
amplicon
detect
specif
peptid
nucleicacid
pna
coval
immobil
onto
si
nanowir
surfac
si
wirebas
sensor
pna
probe
respons
accumul
neg
charg
nanowir
surfac
upon
specif
hybrid
complementari
dna
sequenc
thu
result
increas
electr
resist
may
attribut
sole
neg
charg
dna
sequenc
fig
labelfre
biosensor
reach
detect
limit
fm
within
min
sensit
time
higher
report
method
use
plabel
probe
time
higher
ethidium
bromid
stain
abil
oper
simpl
nonsandwich
multiplex
format
make
method
suitabl
earli
detect
dengu
viru
good
sensit
specif
howev
fet
sensor
usual
achiev
moder
sensit
due
signific
fluctuat
interfac
potenti
aqueou
environ
imped
spectroscopi
timeconsum
techniqu
due
need
record
full
spectrum
within
broad
frequenc
region
henc
use
bioanalyt
purpos
restrict
mainli
character
purpos
auxiliari
techniqu
howev
impedimetrybas
biosensor
may
find
market
low
cost
portabl
analysi
speed
requir
moder
sensit
suffici
mani
perform
paramet
usual
employ
character
evalu
standard
biosens
devic
methodolog
tabl
present
compil
claim
report
lod
assay
time
among
mention
biosensor
dengu
cite
literatur
despit
signific
differ
lod
even
distinct
form
present
significantli
higher
valu
observ
piezoelectr
optic
electrochem
biosensor
also
observ
slight
tendenc
recent
report
biosensor
exhibit
lower
lod
howev
infecti
diseas
attomolarrang
lod
success
detect
dengu
virus
unamplifi
biolog
sampl
must
achiev
although
still
beyond
fundament
limit
common
sens
devic
perform
diagnost
test
strongli
depend
local
condit
use
name
differ
characterist
popul
infecti
agent
eg
infect
preval
genet
variat
pathogen
host
peculiar
test
eg
methodolog
local
diagnost
practic
therefor
evalu
diagnost
test
ideal
carri
particular
condit
includ
multicentr
trial
obvious
test
condit
eventu
determin
particular
inthefield
situat
test
use
exampl
strong
crossreact
may
accept
low
preval
diseas
place
set
usual
lack
proper
valid
standard
mani
rapid
diagnost
test
inthefield
laboratori
usag
partial
due
fact
laboratori
use
inhous
rather
wellstandard
assay
techniqu
strongli
discourag
compar
analysi
aggreg
thu
import
nation
refer
healthcar
entiti
establish
qualiti
assur
program
guarante
product
refer
materi
protocol
effect
qualiti
control
rapid
diagnost
test
regard
special
programm
research
train
tropic
diseas
tdr
sponsor
unicef
unit
nation
develop
programm
undp
world
bank
pediatr
dengu
vaccin
initi
pdvi
underpin
extens
collabor
program
aim
evalu
perform
commerci
avail
diagnost
test
dengu
especi
igmbas
eia
assay
rapid
diag
tabl
report
lod
assay
time
dengu
biosensor
referenc
literatur
discrimin
accord
transduct
mechan
probe
analyt
nostic
test
mainli
basi
comparison
among
specif
goal
assess
differ
pattern
immunoglobulin
antibodi
respons
especi
envisag
accur
diagnosi
acut
dengu
infect
accomplish
task
test
assay
panel
wellcharacter
serum
specimen
person
confirm
dengu
infect
other
confound
infect
condit
inclus
criteria
posit
identif
four
dengu
serotyp
correct
identif
primarysecondari
infect
discrimin
flaviviru
denguelik
diseas
high
specif
toward
system
disord
good
perform
variou
geograph
condit
evalu
compris
four
eia
test
rapid
test
duocassett
panbio
diagnost
sd
biolin
standard
diagnost
dengucheck
zephyr
biomed
india
immunochromatograph
test
hapalysem
pentax
corpor
japan
particl
agglutinationbas
test
three
eia
kit
show
good
agreement
refer
standard
although
gener
render
falseposit
result
dengu
iggposit
rheumatoid
factorposit
dengu
igmnegativemalariaposit
serum
sampl
last
case
test
usag
set
region
dengu
malaria
endem
must
discard
hapalysem
test
exhibit
sensit
compar
highperform
eia
test
although
specif
somewhat
inferior
remain
rapid
test
dengucheck
test
exhibit
far
lowest
sensit
specif
later
flowbas
rapid
test
similar
eia
test
among
test
rapid
test
three
later
flow
test
reach
higher
classif
hapalys
eia
test
concern
easetous
even
four
rapid
test
difficult
result
interpret
basic
due
weak
band
strip
claim
tabl
whole
state
perform
term
sensit
specif
rapid
test
agre
refer
standard
assay
much
eia
test
one
major
limit
evalu
studi
presum
underestim
test
specif
real
situat
unlik
potenti
caus
falseposit
result
would
present
simultan
moreov
sinc
four
dengu
serotyp
repres
equal
proport
sampl
panel
particular
small
number
sampl
reflect
rariti
region
evalu
kit
toward
primari
infect
caus
four
serotyp
could
complet
assess
sinc
rapid
diagnost
test
target
use
patient
obvious
lack
expertis
properli
evalu
assess
perform
test
standard
report
diagnost
accuraci
stard
initi
develop
sequenc
checklist
guid
adequ
report
result
evalu
studi
diagnost
similarli
recogn
enorm
potenti
threat
dengu
diseas
introduct
europ
european
union
start
denfram
project
aim
improv
manag
dengu
diseas
among
human
popul
especi
asia
latinamerica
one
work
program
involv
develop
standard
autom
novel
rapid
diagnost
test
kit
dengu
diagnosi
complet
valid
program
must
includ
multicentr
evalu
ensur
accuraci
robust
test
well
reproduc
result
within
among
differ
assay
lot
take
account
serious
clinic
applic
implic
rapid
diagnost
test
full
evalu
program
test
must
includ
apart
perform
evalu
valid
addit
step
qualiti
control
qualiti
assur
qualiti
control
guarante
correct
function
devic
prolong
use
tradit
procedur
normal
employ
tradit
laboratori
devic
feasibl
dispos
rapid
test
case
randomli
select
unit
product
batch
lot
must
assay
compar
infer
reproduc
final
qualiti
assur
program
hand
demonstr
readi
test
introduc
routin
clinic
diagnosi
institut
evalu
program
like
mention
describ
thu
meritori
attempt
final
establish
order
comparison
criteria
among
vast
portfolio
rapid
diagnost
test
alreadi
avail
although
still
lack
standard
dengu
infecti
diseas
section
focus
promis
theme
futur
biosensor
develop
although
report
citat
found
literatur
concern
specif
applic
mani
theme
diagnosi
dengu
diseas
new
scheme
convent
later
flow
rapid
test
especi
form
cassett
kit
may
offer
addit
advantag
tradit
format
name
need
smaller
sampl
volum
need
dilut
decreas
complex
exampl
recent
develop
cassett
colorimetr
test
panbio
diagnost
australia
success
appli
diagnosi
acutephas
dengu
diseas
individu
south
americanendem
region
cassett
also
perform
better
convent
eia
acut
phase
serum
term
sensit
meanwhil
specif
similar
report
convent
panbio
later
flow
test
thu
panbio
cassett
effect
earli
detect
dengu
igm
antibodi
acut
febril
patient
use
laboratori
set
nonskil
individu
well
biomanguinho
technic
scientif
unit
brazilian
oswaldo
cruz
fiocruz
public
health
research
institut
sign
technolog
transfer
protocol
chembio
diagnost
system
usa
develop
new
rapid
diagnost
test
leptospirosi
canin
leishmaniosi
hiv
three
new
product
base
chembio
fig
possibl
network
geometri
twodimension
analyt
devic
control
fluid
transport
sequenti
deliveri
reagent
arrow
indic
fluid
flow
direct
subfigur
use
multipl
stagger
inlet
common
way
wherea
subfigur
b
employ
geometri
nonoverlap
flow
channel
arriv
time
fluid
detect
region
simultan
introduct
three
inlet
grow
volum
singl
activ
step
depend
engin
length
width
travel
channel
b
channel
length
width
increas
inlet
thu
assur
decreas
flow
rate
henc
slow
fluid
transport
sequenc
dual
path
platform
dpp
technolog
expect
extend
diseas
futur
novel
immunochromatograph
techniqu
essenti
reli
two
intersect
strip
instead
singl
migrat
strip
one
sampl
conjug
marker
sinc
scheme
provid
effect
bind
analyt
bind
site
test
zone
prior
attach
conjug
marker
overal
sensit
enhanc
time
compar
common
later
flow
test
maintain
specif
moreov
known
lengthi
biolog
fluid
migrat
singlepath
later
flow
test
may
thu
obviat
especi
case
aggregationagglutin
larger
supramolecular
analyt
eg
whole
cell
result
obtain
faster
time
period
minim
volum
differ
bodi
fluid
rapid
come
possibl
new
ad
buffer
solut
immedi
color
vanish
test
site
rather
wait
predetermin
often
low
accur
time
interv
addit
cassett
platform
contain
five
test
line
thu
allow
multiplex
test
five
target
reaction
convent
lateralflow
test
possess
one
strip
usual
abl
measur
beyond
singl
analyt
differ
color
latex
particl
conjug
differ
antigen
antibodi
provid
conjug
pad
buffer
solut
thu
facilit
read
result
therefor
dpp
may
consid
improv
userfriendli
test
pointofcar
diagnosi
also
hold
great
promis
rapid
multiplex
detect
identif
dengu
viru
serotyp
anoth
interest
promis
innov
field
immunochromatograph
test
issu
pattern
paperbas
substrat
altern
platform
convent
test
strip
labonachip
platform
paper
familiar
abund
cheap
easytous
stabl
dispos
easili
safe
recycl
inciner
materi
moreov
mani
standard
print
techniqu
eg
photolithographi
inkjet
print
alreadi
avail
function
polym
biolog
speci
element
mass
product
devic
show
feasibl
coat
paper
inkjet
print
ink
biomoleculeattach
microgel
suitabl
materi
link
biomolecul
paper
substrat
thu
preserv
biomolecul
activ
print
usual
white
paper
suitabl
materi
implement
colorimetr
test
name
enzym
smallmolecul
dye
provid
high
contrast
color
substrat
sinc
color
intens
detect
region
usual
function
analyt
concentr
quantit
measur
enabl
detect
method
howev
also
feasibl
like
electrochemiluminesc
radiolabel
enorm
advantag
paperlik
substrat
solidsupport
labonachip
devic
classic
porou
immunochromatograph
substrat
owe
fibrou
natur
paper
intrins
abil
pump
liquid
biolog
sampl
along
imprint
channel
simpl
capillar
thu
avoid
need
extern
pump
pressur
sourc
addit
expens
infrastructur
like
clean
room
requir
fabric
sophist
microdevic
advanc
print
techniqu
work
paperbas
devic
point
toward
multianalyt
multiplex
detect
conveni
extens
convent
lateralflow
test
abil
link
singl
pattern
inlet
variou
detect
region
howev
recent
work
propos
opposit
approach
ie
multianalyt
detect
converg
multipl
inlet
singl
outlet
detect
region
control
transport
liquid
sampl
suitabl
tailor
network
geometri
fluid
flow
rate
requir
autonom
drive
multistep
sequenc
seen
fig
way
complex
process
chemic
amplif
requir
multipl
sequenti
reagent
deliveri
wash
step
extend
highperform
laboratori
bioassay
simpl
pointofcar
devic
way
enhanc
sensit
detect
maintain
easinesstous
price
compar
convent
lateralflow
test
henc
improv
paper
network
may
circumv
usual
lack
sensit
face
mani
current
lateralflow
test
unless
complic
expens
reagent
eg
particl
nanolabel
instrument
eg
light
sourc
detector
use
addit
complex
multitask
process
requir
singleus
activ
step
signific
advantag
compar
current
lateralflow
test
even
chembio
dpp
requir
addit
user
wash
step
label
bind
detect
region
ongo
advanc
theoret
studi
optim
engin
design
fluid
flow
twodimension
paper
devic
certainli
increas
power
use
test
pointofcar
diagnosi
resourcelimit
region
set
altern
perform
flexibl
paperbas
analyt
devic
also
enhanc
pass
twoto
threedimension
structur
fact
like
complex
threedimension
paperbas
structur
may
higher
devic
base
convent
plastic
frame
exampl
common
step
cell
separ
remov
sampl
process
may
significantli
improv
along
liquid
wick
throughout
inner
layer
devic
final
detect
despit
advantag
concern
must
rais
regard
futur
paperbas
kit
name
feroci
competit
convent
laboratori
labonachip
analyt
devic
term
sensit
accuraci
quantit
output
multiplex
abil
b
devic
stabil
shelflif
especi
longdist
transport
longtim
storag
room
temperatur
c
complex
current
lack
knowledg
fluid
flow
biomolecul
immobil
biorecognit
onto
paper
matric
research
dispers
effort
toward
exploit
applic
novel
nanostructur
nanosc
effect
pointofcar
test
nevertheless
expect
devic
may
constitut
exampl
desir
combin
simplic
inexpens
common
diagnost
test
strip
analyt
abil
microfluid
analyt
devic
biosensor
surfac
support
biomolecul
immobil
henc
occurr
biorecognit
event
also
part
signal
transduct
mechan
apart
improv
signal
process
find
suitabl
support
immobil
optim
process
crucial
import
biosensor
concept
develop
regard
new
improv
biomateri
emerg
attract
suitabl
platform
develop
biosensor
modifi
carbon
past
high
conduct
chemic
inert
work
potenti
rang
surfac
area
charg
transport
speed
common
highlight
advantag
includ
low
electr
resist
easi
surfac
renew
possibl
embed
electroact
compound
carbon
past
matrix
thu
avoid
problem
leakag
adher
coat
composit
howev
usual
render
low
biosensor
stabil
reproduc
redox
hydrogel
repres
anoth
class
biomateri
biosens
improv
charg
transfer
abil
chemic
inert
biocompat
owe
high
water
content
howev
tendenc
swell
water
organ
solvent
may
impair
effici
usag
biosens
regard
solgel
matric
appear
advantag
altern
neglig
swell
solvent
pinpoint
includ
oper
room
temperatur
ideal
labil
biomolecul
easi
access
analyt
probe
immobil
within
porou
solgel
network
physic
rigid
chemic
inert
well
high
optic
transpar
high
photochem
thermal
stabil
gener
howev
solidgel
matric
exhibit
low
sensit
reproduc
undesir
chang
biochem
properti
entrap
speci
may
occur
ultim
lead
biolog
inactiv
solgel
materi
also
low
conduct
weak
resist
interfer
import
setback
electrochem
biosensor
way
solgel
hybrid
emerg
conveni
altern
combin
rigid
solgel
materi
biocompat
hydrogel
thu
avoid
unwant
effect
solgel
crack
hydrogel
swell
leakag
immobil
biomolecul
bilay
lipid
membran
blm
usual
form
lipid
molecul
cast
organ
solvent
aqueou
vesicl
dispers
subsequ
surfacebind
constitut
anoth
class
biocompat
immobil
matric
blm
also
allow
better
electron
exchang
redox
biomolecul
electrod
tighter
stabl
attach
blm
solid
conduct
surfac
achiev
selfassembl
deposit
onto
conduct
polym
physicochem
instabl
immobil
biomolecul
result
lack
reproduc
unreli
major
concern
current
biosensor
especi
affinitybas
biosensor
name
immunosensor
genosensor
newli
develop
mip
may
surpass
limit
mip
form
solvent
remov
polymerentrap
biomolecul
lead
format
imprint
nanocav
becom
perman
memori
size
shape
extract
molecul
imprint
polym
abl
select
rebind
complementari
print
molecul
tailor
surfac
predetermin
select
molecular
recognit
properti
use
convent
labil
immobil
biomoleculebas
surfac
avoid
howev
improv
mipbas
biosensor
must
reli
sensit
select
reusabl
relat
surfac
regener
abil
enhanc
inde
last
properti
one
major
highlight
smart
polym
new
kind
transduc
surfac
amen
biosensor
develop
polym
undergo
larg
physicochem
structur
chang
respons
small
chang
extern
condit
eg
temperatur
light
electromagnet
field
ph
gener
extern
physicochem
stimulu
reach
given
threshold
sudden
collaps
polym
structur
rapidli
trigger
pronounc
conform
chang
attach
biorecognit
molecul
revers
stimulu
appli
polym
attach
biomolecul
regener
origin
configur
bioactiv
make
possibl
use
multipl
cycl
biosens
expect
yield
type
yesno
respons
smart
polymerbas
biosensor
may
use
suitabl
molecular
switch
bioelectron
applic
nanotechnolog
provid
brand
new
rang
structur
tool
improv
physicochem
characterist
manipul
biolog
system
socal
field
nanobiotechnolog
particular
concept
develop
biosensor
rapid
diagnost
test
greatli
benefit
advent
nanomateri
may
act
immobil
support
also
signal
amplifi
metal
nanoparticl
especi
gnp
probabl
best
known
wide
use
nanostructur
biosens
provid
high
sn
stabil
metal
nanoparticl
advantag
fluoresc
label
also
suitabl
incorpor
highdens
microchipbas
devic
addit
easili
synthesiz
function
room
temperatur
commonli
simpl
selfassembl
particular
nanoparticl
combin
fluoresc
tag
detect
form
socal
quantum
dot
qd
kind
nanoparticl
much
brighter
due
high
quantum
yield
photost
convent
fluorophor
color
directli
correl
particl
size
emiss
singl
welldefin
wavelength
excit
peculiar
highli
nonoverlap
broad
absorpt
spectra
narrow
emiss
spectra
alli
possibl
excit
qd
differ
size
henc
differ
emiss
peak
singlewavelength
excit
sourc
make
particl
suitabl
multiplex
analysi
complex
biolog
system
label
differ
biolog
target
qd
differ
size
carbon
nanotub
cnt
constitut
anoth
emerg
kind
nanostructur
biosensor
construct
abil
bind
surfac
larg
divers
bioactiv
biomolecul
coval
noncoval
interact
belong
fulleren
chemic
famili
roughli
resembl
hollow
cylind
porou
wall
compos
carbon
network
behav
like
microcryst
molecular
dimens
configur
assur
enlarg
area
immobil
biomolecul
cnt
electr
conduct
compar
copper
much
higher
polym
also
physic
robust
chemic
inert
toward
chemic
characterist
favor
peculiar
rang
improv
electron
properti
make
cnt
ideal
biosens
usual
reli
cnt
surfac
function
way
enhanc
biocompat
improv
select
bind
biotarget
ad
cnt
conduct
polym
decreas
charg
transfer
resist
masstransf
imped
higher
extent
nanomateri
manufactur
cnt
howev
complex
usual
result
high
structur
variabl
within
pool
cnt
subsequ
lack
reproduc
electr
properti
nanotub
array
high
densiti
may
minim
setback
due
statist
averag
effect
also
lead
multiplex
analysi
mani
biolog
target
name
cheap
simultan
detect
mani
specif
gene
cntgnp
composit
produc
function
cnt
surfac
also
employ
sensit
select
detect
biotarget
conduct
polym
nanowir
name
polyanilin
also
develop
suitabl
nanostructur
ultrasensit
biomolecul
detect
apart
easi
process
possess
larg
surfac
area
high
chemic
specif
tunabl
conduct
quasion
dimension
structur
nanowir
provid
highli
sensit
specif
detect
henc
high
surfacevolum
ratio
nevertheless
applic
electrochem
biosensor
limit
difficulti
adhes
pattern
electrod
new
dnaprotein
conjug
recent
emerg
valuabl
nanoengin
structur
medic
diagnost
biosensor
given
wide
rang
interact
observ
compon
mani
cellular
process
remark
exampl
concern
pna
possess
neutral
peptid
backbon
unlik
true
nucleicacid
allow
highli
specif
select
bind
dna
counterpart
low
rel
vari
ionic
strength
therefor
amen
probe
dna
hybrid
interest
structur
singlemolecul
dna
detect
dna
nanopor
usual
form
coval
link
specif
singlechain
dnaprob
pore
protein
eg
staphylococcu
aureu
detect
principl
reli
product
distinct
pattern
ionic
current
chang
differ
singlechain
dna
cross
nanochannel
accord
averag
time
interv
bind
immobil
chain
direct
correl
complementar
degre
targetdna
chain
thu
detect
singlebas
resolut
drawback
system
unfeas
nucleotid
sequenc
sinc
dna
sequenc
nucleotid
within
pore
given
instant
contribut
indistinct
overal
resist
also
effect
use
high
frequenc
current
decreas
experiment
nois
even
possibl
altern
highdens
probe
microarray
attract
next
gener
nanoporebas
biosensor
magnet
nanoparticl
also
known
magnet
nanobead
magnet
nanospher
simpli
nanomagnet
also
emerg
interest
structur
biosens
purpos
abil
stabli
bind
biolog
target
magnet
particl
gener
easili
manufactur
wide
rang
microor
nanos
diamet
basic
magnet
nanoparticl
similar
micros
counterpart
magnet
microbead
concern
structur
biolog
reactiv
biorecognit
mechan
characterist
compar
typic
huge
amount
magnet
nanobead
even
low
amount
magnet
microbead
easili
detect
simpl
optic
microscopi
magnet
detect
howev
higher
surfacevolum
ratio
nanobead
provid
much
bind
site
bioprob
biotarget
anchor
henc
higher
sn
ratio
maxim
paramet
extrem
import
labelbas
system
whose
perform
sensit
select
reproduc
much
depend
level
nonspecif
background
signal
abil
label
detect
moreov
use
nanomagnet
allow
avoid
size
mismatch
micros
magnet
label
nanos
biolog
probe
target
magnet
particlebound
bioprob
captur
biotarget
exposur
strong
magnet
field
collect
align
magnet
moment
magnet
particl
occur
yield
measur
specif
signal
signal
given
surfacebound
magnet
particl
proport
biotarget
concentr
sinc
magnet
signal
function
nanomagnet
depend
spatial
orient
unbound
magnet
nanoparticlebioprob
complex
randomli
orient
net
signal
set
particl
respons
earlierment
magnet
wash
effect
often
magnet
label
use
separ
preconcentr
biotarget
rather
detect
step
addit
label
usual
metal
nanoparticl
fluorophor
employ
detect
strategi
commonli
reli
initi
captur
target
probefunction
nanomagnet
follow
releas
debind
final
detect
may
signific
improv
detect
exampl
viral
genom
rna
sinc
rna
enrich
due
magnet
confin
also
preclud
effect
common
interfer
inhibitor
rna
usual
exist
thermolys
viralcontain
sampl
multistep
process
howev
may
result
delay
analysi
sampl
dilut
moreov
wider
applic
magnet
nanoparticl
biosensor
requir
enhanc
field
sensit
reduct
nois
background
final
noteworthi
combin
nanomateri
new
biosens
surfac
like
solgel
materi
synerg
improv
individu
perform
like
better
conduct
gener
remark
signal
amplif
anoth
mileston
biosensor
develop
concern
issu
data
process
fact
usag
rapid
diagnost
test
nonexpert
may
lead
misus
result
misinterpret
clear
exampl
common
improp
usag
colorimetr
test
strip
patient
disturb
visual
accuraci
balanc
merg
inthefield
test
remot
data
analysi
interpret
compet
clinic
staff
may
desir
regard
telemedicin
emerg
attract
system
healthcar
improv
develop
countri
allow
unskil
person
provid
use
healthcar
remot
set
certainli
benefit
unend
advanc
inform
technolog
especi
focus
develop
miniatur
analyt
devic
integr
hardwar
name
imag
acquisit
cell
phone
camera
suitabl
softwar
storag
result
download
hard
copi
directli
transfer
onlin
remot
healthcar
unit
central
process
interpret
expert
person
process
result
afterward
return
tester
almost
realtim
interest
applic
telemedicin
approach
alreadi
develop
coupl
pattern
paperbas
microfluid
platform
pointofcar
remot
multiplex
test
sinc
color
intens
imag
strongli
vari
local
light
userdepend
condit
improv
local
imag
captur
must
achiev
way
provid
accur
remot
interpret
result
ms
anoth
promis
techniqu
detect
identif
pathogen
microorgan
although
repres
differ
paradigm
detect
coupl
power
comput
softwar
ms
abl
unambigu
detect
presenc
quantifi
unidentifi
microorgan
unknown
sampl
compar
result
mass
spectra
includ
databas
infecti
agent
system
also
abl
relat
unknown
organ
encount
formerli
could
use
straightforward
identif
dengu
serotyp
also
dengu
genotyp
outbreak
form
commerci
packag
integr
platform
strategi
alreadi
appli
success
inclus
human
sever
acut
respiratori
syndrom
sar
viru
coronaviru
famili
rapid
inexpens
method
global
surveil
emerg
influenza
viru
genotyp
miniatur
ms
devic
still
remain
hard
challeng
custom
kit
compris
modul
genom
extract
amplif
pcr
alreadi
avail
sever
infecti
agent
like
current
rapid
diagnost
test
correspond
timebridg
convent
laboratori
apparatu
futur
noninvas
sensor
vivo
monitor
gener
rapid
test
pointofcar
analysi
still
suffer
skeptic
world
medic
commun
question
validityus
singleanalyt
measur
interpret
result
nonclinician
certainli
contribut
addit
proper
valid
standard
test
still
requir
without
regulatori
approv
test
commerci
hardli
obtain
nevertheless
suitabl
rapid
diagnost
test
demonstr
valid
process
must
complement
addit
figur
merit
implement
routin
diagnosi
dengu
viru
difficult
cultiv
propag
laboratori
probabl
due
wide
geograph
serotyp
genotyp
variabl
major
obstacl
toward
develop
implement
rapid
diagnost
test
dengu
infect
still
long
way
run
inthebench
scheme
prototyp
fulli
develop
commerci
attract
biosens
devic
whose
wider
util
still
shadow
wellestablish
wellperform
laboratori
assay
unfortun
experiment
prerog
use
welldefin
pure
synthet
sampl
often
hinder
detail
studi
conclus
effect
potenti
interf
substanc
coldchain
support
massiv
adequ
deliveri
rapid
diagnost
test
clinic
set
endus
remot
tropic
region
handicap
frequent
irregular
power
suppli
region
huge
cost
associ
transport
despit
challeng
rapid
diagnost
test
must
consid
valuabl
altern
rather
competitor
laboratorybas
analyt
devic
methodolog
even
loss
sensit
select
must
accept
pointofcar
test
fact
rapid
screen
larg
amount
sampl
may
speed
proper
decis
make
clinician
convent
labbas
bioanalyt
techniqu
use
afterward
confirm
better
character
infect
pathogen
reusabl
diagnost
test
must
avoid
deal
infecti
pathogen
thu
explain
grow
interest
develop
chipbas
dispos
test
consensu
effici
rapid
diagnost
test
dengu
diseas
multiplex
devic
detect
identif
four
dengu
serotyp
futur
develop
advanc
fundament
engin
scienc
certainli
enrich
whole
pool
knowledg
rapid
diagnost
test
also
improv
microand
nanofabr
process
mass
product
increas
costeffect
basi
well
